Europe Urology Drugs Market Report 2017

Europe Urology Drugs Market Report 2017

1 Urology Drugs Overview

1.1 Product Overview and Scope of Urology Drugs

1.2 Classification of Urology Drugs

1.2.1 ? (alpha) - blockers

1.2.2 5 ?-reductase inhibitors

1.3 Application of Urology Drugs

1.3.1 Hospital

1.3.2 Clinic

1.4 Urology Drugs Market by Countries

1.4.1 Germany Status and Prospect (2012-2022)

1.4.2 France Status and Prospect (2012-2022)

1.4.3 UK Status and Prospect (2012-2022)

1.4.4 Russia Status and Prospect (2012-2022)

1.4.5 Italy Status and Prospect (2012-2022)

1.4.6 Spain Status and Prospect (2012-2022)

1.4.7 Benelux Status and Prospect (2012-2022)

1.5 Europe Market Size (Value and Volume) of Urology Drugs (2012-2022)

1.5.1 Europe Urology Drugs Sales and Growth Rate (2012-2022)

1.5.2 Europe Urology Drugs Revenue and Growth Rate (2012-2022)

2 Europe Urology Drugs by Manufacturers, Type and Application

2.1 Europe Urology Drugs Market Competition by Manufacturers

2.1.1 Europe Urology Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Urology Drugs Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Urology Drugs (Volume and Value) by Type

2.2.1 Europe Urology Drugs Sales and Market Share by Type (2012-2017)

2.2.2 Europe Urology Drugs Revenue and Market Share by Type (2012-2017)

2.3 Europe Urology Drugs (Volume and Value) by Countries

2.3.1 Europe Urology Drugs Sales and Market Share by Countries (2012-2017)

2.3.2 Europe Urology Drugs Revenue and Market Share by Countries (2012-2017)

2.4 Europe Urology Drugs (Volume) by Application

3 Germany Urology Drugs (Volume, Value and Sales Price)

3.1 Germany Urology Drugs Sales and Value (2012-2017)

3.1.1 Germany Urology Drugs Sales and Growth Rate (2012-2017)

3.1.2 Germany Urology Drugs Revenue and Growth Rate (2012-2017)

3.1.3 Germany Urology Drugs Sales Price Trend (2012-2017)

3.2 Germany Urology Drugs Sales and Market Share by Manufacturers

3.3 Germany Urology Drugs Sales and Market Share by Type

3.4 Germany Urology Drugs Sales and Market Share by Application

4 France Urology Drugs (Volume, Value and Sales Price)

4.1 France Urology Drugs Sales and Value (2012-2017)

4.1.1 France Urology Drugs Sales and Growth Rate (2012-2017)

4.1.2 France Urology Drugs Revenue and Growth Rate (2012-2017)

4.1.4 France Urology Drugs Sales Price Trend (2012-2017)

4.2 France Urology Drugs Sales and Market Share by Manufacturers

4.3 France Urology Drugs Sales and Market Share by Type

4.4 France Urology Drugs Sales and Market Share by Application

5 UK Urology Drugs (Volume, Value and Sales Price)

5.1 UK Urology Drugs Sales and Value (2012-2017)

5.1.1 UK Urology Drugs Sales and Growth Rate (2012-2017)

5.1.2 UK Urology Drugs Revenue and Growth Rate (2012-2017)

5.1.5 UK Urology Drugs Sales Price Trend (2012-2017)

5.2 UK Urology Drugs Sales and Market Share by Manufacturers

5.3 UK Urology Drugs Sales and Market Share by Type

5.4 UK Urology Drugs Sales and Market Share by Application

6 Russia Urology Drugs (Volume, Value and Sales Price)

6.1 Russia Urology Drugs Sales and Value (2012-2017)

6.1.1 Russia Urology Drugs Sales and Growth Rate (2012-2017)

6.1.2 Russia Urology Drugs Revenue and Growth Rate (2012-2017)

6.1.6 Russia Urology Drugs Sales Price Trend (2012-2017)

6.2 Russia Urology Drugs Sales and Market Share by Manufacturers

6.3 Russia Urology Drugs Sales and Market Share by Type

6.4 Russia Urology Drugs Sales and Market Share by Application

7 Italy Urology Drugs (Volume, Value and Sales Price)

7.1 Italy Urology Drugs Sales and Value (2012-2017)

7.1.1 Italy Urology Drugs Sales and Growth Rate (2012-2017)

7.1.2 Italy Urology Drugs Revenue and Growth Rate (2012-2017)

7.1.7 Italy Urology Drugs Sales Price Trend (2012-2017)

7.2 Italy Urology Drugs Sales and Market Share by Manufacturers

7.3 Italy Urology Drugs Sales and Market Share by Type

7.4 Italy Urology Drugs Sales and Market Share by Application

8 Spain Urology Drugs (Volume, Value and Sales Price)

8.1 Spain Urology Drugs Sales and Value (2012-2017)

8.1.1 Spain Urology Drugs Sales and Growth Rate (2012-2017)

8.1.2 Spain Urology Drugs Revenue and Growth Rate (2012-2017)

8.1.8 Spain Urology Drugs Sales Price Trend (2012-2017)

8.2 Spain Urology Drugs Sales and Market Share by Manufacturers

8.3 Spain Urology Drugs Sales and Market Share by Type

8.4 Spain Urology Drugs Sales and Market Share by Application

9 Benelux Urology Drugs (Volume, Value and Sales Price)

9.1 Benelux Urology Drugs Sales and Value (2012-2017)

9.1.1 Benelux Urology Drugs Sales and Growth Rate (2012-2017)

9.1.2 Benelux Urology Drugs Revenue and Growth Rate (2012-2017)

9.1.9 Benelux Urology Drugs Sales Price Trend (2012-2017)

9.2 Benelux Urology Drugs Sales and Market Share by Manufacturers

9.3 Benelux Urology Drugs Sales and Market Share by Type

9.4 Benelux Urology Drugs Sales and Market Share by Application

10 Europe Urology Drugs Manufacturers Analysis

10.1 Astellas

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Urology Drugs Product Type, Application and Specification

10.1.2.1 ? (alpha) - blockers

10.1.2.2 5 ?-reductase inhibitors

10.1.3 Astellas Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.1.4 Main Business/Business Overview

10.2 Endo

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Urology Drugs Product Type, Application and Specification

10.2.2.1 ? (alpha) - blockers

10.2.2.2 5 ?-reductase inhibitors

10.2.3 Endo Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.2.4 Main Business/Business Overview

10.3 GP Pharm

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Urology Drugs Product Type, Application and Specification

10.3.2.1 ? (alpha) - blockers

10.3.2.2 5 ?-reductase inhibitors

10.3.3 GP Pharm Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.3.4 Main Business/Business Overview

10.4 Tolmar

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Urology Drugs Product Type, Application and Specification

10.4.2.1 ? (alpha) - blockers

10.4.2.2 5 ?-reductase inhibitors

10.4.3 Tolmar Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.4.4 Main Business/Business Overview

11 Urology Drugs Manufacturing Cost Analysis

11.1 Urology Drugs Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Urology Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Urology Drugs Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Urology Drugs Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe Urology Drugs Market Forecast (2017-2022)

14.1 Germany Urology Drugs Sales Forecast (2017-2022)

14.2 France Urology Drugs Sales Forecast (2017-2022)

14.3 UK Urology Drugs Sales Forecast (2017-2022)

14.4 Russia Urology Drugs Sales Forecast (2017-2022)

14.5 Italy Urology Drugs Sales Forecast (2017-2022)

14.6 Spain Urology Drugs Sales Forecast (2017-2022)

14.7 Benelux Urology Drugs Sales Forecast (2017-2022)

14.8 Europe Urology Drugs Sales Forecast by Type (2017-2022)

14.9 Europe Urology Drugs Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

Methodology

Analyst Introduction

Data Source

Figure Picture of Urology Drugs

Table Classification of Urology Drugs

Figure Europe Sales Market Share of Urology Drugs by Type in 2015

Figure ? (alpha) - blockers Picture

Figure 5 ?-reductase inhibitors Picture

Table Application of Urology Drugs

Figure Europe Sales Market Share of Urology Drugs by Application in 2015

Figure Hospital Examples

Figure Clinic Examples

Figure Germany Urology Drugs Revenue and Growth Rate (2012-2022)

Figure France Urology Drugs Revenue and Growth Rate (2012-2022)

Figure UK Urology Drugs Revenue and Growth Rate (2012-2022)

Figure Russia Urology Drugs Revenue and Growth Rate (2012-2022)

Figure Italy Urology Drugs Revenue and Growth Rate (2012-2022)

Figure Spain Urology Drugs Revenue and Growth Rate (2012-2022)

Figure Benelux Urology Drugs Revenue and Growth Rate (2012-2022)

Figure Europe Urology Drugs Sales and Growth Rate (2012-2022)

Figure Europe Urology Drugs Revenue and Growth Rate (2012-2022)

Table Europe Urology Drugs Sales of Key Manufacturers (2015 and 2016)

Table Europe Urology Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Urology Drugs Sales Share by Manufacturers

Figure 2016 Urology Drugs Sales Share by Manufacturers

Table Europe Urology Drugs Revenue by Manufacturers (2015 and 2016)

Table Europe Urology Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Urology Drugs Revenue Share by Manufacturers

Table 2016 Europe Urology Drugs Revenue Share by Manufacturers

Table Europe Urology Drugs Sales and Market Share by Type (2012-2017)

Table Europe Urology Drugs Sales Share by Type (2012-2017)

Figure Sales Market Share of Urology Drugs by Type (2012-2017)

Figure Europe Urology Drugs Sales Growth Rate by Type (2012-2017)

Table Europe Urology Drugs Revenue and Market Share by Type (2012-2017)

Table Europe Urology Drugs Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Urology Drugs by Type (2012-2017)

Figure Europe Urology Drugs Revenue Growth Rate by Type (2012-2017)

Table Europe Urology Drugs Sales and Market Share by Countries (2012-2017)

Table Europe Urology Drugs Sales Share by Countries (2012-2017)

Figure Sales Market Share of Urology Drugs by Countries (2012-2017)

Table Europe Urology Drugs Revenue and Market Share by Countries (2012-2017)

Table Europe Urology Drugs Revenue Share by Countries (2012-2017)

Figure Revenue Market Share of Urology Drugs by Countries (2012-2017)

Table Europe Urology Drugs Sales and Market Share by Application (2012-2017)

Table Europe Urology Drugs Sales Share by Application (2012-2017)

Figure Sales Market Share of Urology Drugs by Application (2012-2017)

Figure Germany Urology Drugs Sales and Growth Rate (2012-2017)

Figure Germany Urology Drugs Revenue and Growth Rate (2012-2017)

Figure Germany Urology Drugs Sales Price Trend (2012-2017)

Table Germany Urology Drugs Sales by Manufacturers (2015 and 2016)

Table Germany Urology Drugs Market Share by Manufacturers (2015 and 2016)

Table Germany Urology Drugs Sales by Type (2015 and 2016)

Table Germany Urology Drugs Market Share by Type (2015 and 2016)

Table Germany Urology Drugs Sales by Application (2015 and 2016)

Table Germany Urology Drugs Market Share by Application (2015 and 2016)

Figure France Urology Drugs Sales and Growth Rate (2012-2017)

Figure France Urology Drugs Revenue and Growth Rate (2012-2017)

Figure France Urology Drugs Sales Price Trend (2012-2017)

Table France Urology Drugs Sales by Manufacturers (2015 and 2016)

Table France Urology Drugs Market Share by Manufacturers (2015 and 2016)

Table France Urology Drugs Sales by Type (2015 and 2016)

Table France Urology Drugs Market Share by Type (2015 and 2016)

Table France Urology Drugs Sales by Application (2015 and 2016)

Table France Urology Drugs Market Share by Application (2015 and 2016)

Figure UK Urology Drugs Sales and Growth Rate (2012-2017)

Figure UK Urology Drugs Revenue and Growth Rate (2012-2017)

Figure UK Urology Drugs Sales Price Trend (2012-2017)

Table UK Urology Drugs Sales by Manufacturers (2015 and 2016)

Table UK Urology Drugs Market Share by Manufacturers (2015 and 2016)

Table UK Urology Drugs Sales by Type (2015 and 2016)

Table UK Urology Drugs Market Share by Type (2015 and 2016)

Table UK Urology Drugs Sales by Application (2015 and 2016)

Table UK Urology Drugs Market Share by Application (2015 and 2016)

Figure Russia Urology Drugs Sales and Growth Rate (2012-2017)

Figure Russia Urology Drugs Revenue and Growth Rate (2012-2017)

Figure Russia Urology Drugs Sales Price Trend (2012-2017)

Table Russia Urology Drugs Sales by Manufacturers (2015 and 2016)

Table Russia Urology Drugs Market Share by Manufacturers (2015 and 2016)

Table Russia Urology Drugs Sales by Type (2015 and 2016)

Table Russia Urology Drugs Market Share by Type (2015 and 2016)

Table Russia Urology Drugs Sales by Application (2015 and 2016)

Table Russia Urology Drugs Market Share by Application (2015 and 2016)

Figure Italy Urology Drugs Sales and Growth Rate (2012-2017)

Figure Italy Urology Drugs Revenue and Growth Rate (2012-2017)

Figure Italy Urology Drugs Sales Price Trend (2012-2017)

Table Italy Urology Drugs Sales by Manufacturers (2015 and 2016)

Table Italy Urology Drugs Market Share by Manufacturers (2015 and 2016)

Table Italy Urology Drugs Sales by Type (2015 and 2016)

Table Italy Urology Drugs Market Share by Type (2015 and 2016)

Table Italy Urology Drugs Sales by Application (2015 and 2016)

Table Italy Urology Drugs Market Share by Application (2015 and 2016)

Figure Spain Urology Drugs Sales and Growth Rate (2012-2017)

Figure Spain Urology Drugs Revenue and Growth Rate (2012-2017)

Figure Spain Urology Drugs Sales Price Trend (2012-2017)

Table Spain Urology Drugs Sales by Manufacturers (2015 and 2016)

Table Spain Urology Drugs Market Share by Manufacturers (2015 and 2016)

Table Spain Urology Drugs Sales by Type (2015 and 2016)

Table Spain Urology Drugs Market Share by Type (2015 and 2016)

Table Spain Urology Drugs Sales by Application (2015 and 2016)

Table Spain Urology Drugs Market Share by Application (2015 and 2016)

Figure Benelux Urology Drugs Sales and Growth Rate (2012-2017)

Figure Benelux Urology Drugs Revenue and Growth Rate (2012-2017)

Figure Benelux Urology Drugs Sales Price Trend (2012-2017)

Table Benelux Urology Drugs Sales by Manufacturers (2015 and 2016)

Table Benelux Urology Drugs Market Share by Manufacturers (2015 and 2016)

Table Benelux Urology Drugs Sales by Type (2015 and 2016)

Table Benelux Urology Drugs Market Share by Type (2015 and 2016)

Table Benelux Urology Drugs Sales by Application (2015 and 2016)

Table Benelux Urology Drugs Market Share by Application (2015 and 2016)

Table Urology Drugs Basic Information List

Table Astellas Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Astellas Urology Drugs Sales Market Share (2012-2017)

Table Endo Basic Information List

Table Endo Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Endo Urology Drugs Sales Market Share (2012-2017)

Table GP Pharm Basic Information List

Table GP Pharm Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table GP Pharm Urology Drugs Sales Market Share (2012-2017)

Table Tolmar Basic Information List

Table Tolmar Urology Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Tolmar Urology Drugs Sales Market Share (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Urology Drugs

Figure Manufacturing Process Analysis of Urology Drugs

Figure Urology Drugs Industrial Chain Analysis

Table Raw Materials Sources of Urology Drugs Major Manufacturers in 2015

Table Major Buyers of Urology Drugs

Table Distributors/Traders List

Figure Germany Urology Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Germany Urology Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure France Urology Drugs Sales and Growth Rate Forecast (2017-2022)

Figure France Urology Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure UK Urology Drugs Sales and Growth Rate Forecast (2017-2022)

Figure UK Urology Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure Russia Urology Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Russia Urology Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure Italy Urology Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Italy Urology Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure Spain Urology Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Spain Urology Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure Benelux Urology Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Benelux Urology Drugs Revenue and Growth Rate Forecast (2017-2022)

Table Europe Urology Drugs Sales Forecast by Type (2017-2022)

Table Europe Urology Drugs Sales Forecast by Application (2017-2022)